ME02147B - Jedinjenje sa topikalnom primjenom za aktinične keratoze - Google Patents

Jedinjenje sa topikalnom primjenom za aktinične keratoze

Info

Publication number
ME02147B
ME02147B MEP-2015-38A MEP3815A ME02147B ME 02147 B ME02147 B ME 02147B ME P3815 A MEP3815 A ME P3815A ME 02147 B ME02147 B ME 02147B
Authority
ME
Montenegro
Prior art keywords
treatment
actinic keratosis
topical composition
mixtures
group
Prior art date
Application number
MEP-2015-38A
Other languages
English (en)
French (fr)
Inventor
Manfred Melzer
Carmen Matthies
Klaus Treudler
Christoph Willers
Henning Mallwitz
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40039993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02147(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ME02147B publication Critical patent/ME02147B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

1. Jedinjenje u vidu gela sa topikalnom primjenom sadrzi(a) 0,25 do 4,5 tez.-% aktivnog sastojka za lecenje aktinicne keratoze izabrane iz grupe koja se sastoji ad inhibitora ciklooksigenaze, imunomodulatora sa topikalnom primenom, antimetabolici iii njihovih mesavina ,(b) keratol iticki aktivno sredstvo,(c) formirac gela , i (d) organski rastvarac izabran iz grupe koja se sastoji ad C1-C10 alkohola, estara C1-C10 alkohola sa C1-C10 karboksilnim kiselinama, C3-C8 alkil ketona, i njihovih mesavinai sadrze manje od 5 tez.-% vode za upotrebu u lecenju aktinicne keratoze.
MEP-2015-38A 2008-07-07 2009-06-29 Jedinjenje sa topikalnom primjenom za aktinične keratoze ME02147B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08012237A EP2143421A1 (en) 2008-07-07 2008-07-07 Topical composition for the treatment of actinic keratosis
PCT/EP2009/004682 WO2010003568A1 (en) 2008-07-07 2009-06-29 Topical composition for the treatment of actinic keratosis
EP09776876.6A EP2315581B1 (en) 2008-07-07 2009-06-29 Topical composition for the treatment of actinic keratosis

Publications (1)

Publication Number Publication Date
ME02147B true ME02147B (me) 2015-10-20

Family

ID=40039993

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2015-38A ME02147B (me) 2008-07-07 2009-06-29 Jedinjenje sa topikalnom primjenom za aktinične keratoze

Country Status (31)

Country Link
US (1) US8569320B2 (me)
EP (2) EP2143421A1 (me)
JP (2) JP5654987B2 (me)
KR (1) KR101689898B1 (me)
CN (2) CN104825384A (me)
AR (1) AR072685A1 (me)
AU (1) AU2009267471B2 (me)
BR (1) BRPI0915439B8 (me)
CA (1) CA2729974A1 (me)
CL (1) CL2010001642A1 (me)
CO (1) CO6351710A2 (me)
CY (1) CY1116111T1 (me)
DK (1) DK2315581T3 (me)
EA (1) EA019533B1 (me)
EC (1) ECSP11010762A (me)
ES (1) ES2532948T3 (me)
HR (1) HRP20150222T1 (me)
IL (1) IL210134A (me)
ME (1) ME02147B (me)
MX (1) MX2011000054A (me)
MY (1) MY158428A (me)
NZ (1) NZ590288A (me)
PE (1) PE20110330A1 (me)
PL (1) PL2315581T3 (me)
PT (1) PT2315581E (me)
RS (1) RS53887B1 (me)
SI (1) SI2315581T1 (me)
TW (1) TWI433692B (me)
UA (1) UA101044C2 (me)
WO (1) WO2010003568A1 (me)
ZA (1) ZA201100653B (me)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101791705B1 (ko) * 2009-10-08 2017-10-30 바이엘 컨수머 케어 악티엔게젤샤프트 저 에테르 조성물 및 전달 장치
JP5950528B2 (ja) * 2011-09-30 2016-07-13 小林製薬株式会社 皮膜形成性外用製剤
AU2012324031B2 (en) * 2011-12-12 2015-10-08 Leo Laboratories Limited Gel compositions
NZ606177A (en) * 2012-01-30 2014-03-28 Dolorgiet Gmbh & Co Kg Compositions for the treatment of actinic keratosis
GB201222405D0 (en) * 2012-12-12 2013-01-23 Leo Lab Ltd Gel compositions
RU2017106013A (ru) * 2014-07-31 2018-08-28 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая композиция изотретиноина для перорального приема
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
MX385113B (es) * 2015-07-10 2025-03-14 Infectopharm Arzneimittel Und Consilium Gmbh Uso de hidróxido de potasio en el tratamiento de la queratosis actínica.
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
PT3592355T (pt) 2017-03-10 2026-02-03 Atnx Spv Llc Kx2-391/kx-01 para utilização no tratamento da queratose actínica
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof
US20220175769A1 (en) * 2020-12-08 2022-06-09 Ankh Life Sciences Limited Method of treatment of actinic keratoses
DK202370132A1 (en) * 2023-03-14 2024-10-10 Repoceuticals Aps Compositions for use in the treatment of actinic keratosis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) 1957-08-06 S-eluorourace
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5167649A (en) * 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
JP3117502B2 (ja) * 1991-08-27 2000-12-18 株式会社資生堂 皮膚外用剤
US5627187A (en) * 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
KR20030097619A (ko) * 1996-06-20 2003-12-31 라비팜 에스.아. 여드름의 국소 치료 제형
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US6462071B1 (en) * 2000-03-02 2002-10-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
AU2004266502B2 (en) * 2002-10-25 2010-09-23 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
JP5324091B2 (ja) * 2004-06-24 2013-10-23 アイデックス ラボラトリーズ，インコーポレイティド 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法
US20070053984A1 (en) 2005-03-03 2007-03-08 Monique Spann-Wade Topical gels compositions
EP1890687B1 (en) * 2005-06-14 2008-09-17 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable pharmaceutical gel of diclofenac sodium
US7851431B2 (en) * 2005-07-27 2010-12-14 Prescription Dispensing Laboratories Treatment of actinic keratoses with calcium channel blockers
US20070264317A1 (en) * 2006-05-15 2007-11-15 Perrigo Israel Pharmaceuticals Ltd. Imiquimod cream formulation
WO2008047857A1 (fr) * 2006-10-18 2008-04-24 Fujifilm Corporation Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé

Also Published As

Publication number Publication date
AU2009267471A1 (en) 2010-01-14
HK1154793A1 (en) 2012-05-04
UA101044C2 (ru) 2013-02-25
SI2315581T1 (sl) 2015-05-29
AR072685A1 (es) 2010-09-15
CN104825384A (zh) 2015-08-12
PT2315581E (pt) 2015-04-02
ECSP11010762A (es) 2012-03-30
CA2729974A1 (en) 2010-01-14
JP2015038129A (ja) 2015-02-26
JP2011526934A (ja) 2011-10-20
EP2143421A1 (en) 2010-01-13
MX2011000054A (es) 2011-11-04
RS53887B1 (sr) 2015-08-31
DK2315581T3 (en) 2015-03-23
PE20110330A1 (es) 2011-06-11
ES2532948T3 (es) 2015-04-06
US8569320B2 (en) 2013-10-29
WO2010003568A8 (en) 2011-02-03
KR20110027838A (ko) 2011-03-16
EP2315581B1 (en) 2014-12-17
JP5654987B2 (ja) 2015-01-14
BRPI0915439A2 (pt) 2015-11-10
CN102088957A (zh) 2011-06-08
HRP20150222T1 (hr) 2015-05-22
EA019533B1 (ru) 2014-04-30
EA201100020A1 (ru) 2011-06-30
US20110301130A1 (en) 2011-12-08
EP2315581A1 (en) 2011-05-04
ZA201100653B (en) 2011-10-26
PL2315581T3 (pl) 2015-06-30
TWI433692B (zh) 2014-04-11
CY1116111T1 (el) 2017-02-08
BRPI0915439B8 (pt) 2021-05-25
CL2010001642A1 (es) 2011-04-08
AU2009267471B2 (en) 2014-06-05
KR101689898B1 (ko) 2016-12-26
CO6351710A2 (es) 2011-12-20
IL210134A0 (en) 2011-02-28
NZ590288A (en) 2012-08-31
MY158428A (en) 2016-10-14
IL210134A (en) 2015-06-30
BRPI0915439B1 (pt) 2019-10-08
WO2010003568A1 (en) 2010-01-14
TW201006507A (en) 2010-02-16

Similar Documents

Publication Publication Date Title
ME02147B (me) Jedinjenje sa topikalnom primjenom za aktinične keratoze
AR112074A2 (es) Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3
WO2008037789A8 (en) Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
WO2008131860A3 (de) Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung und deren verwendung
CR9587A (es) Derivados de piridazina
ECSP10010556A (es) Piridinas y pirazinas como inhibidores de pi3k
PH12015500105B1 (en) Lavatory treatment device
JP2013515742A5 (me)
JP2009527613A5 (me)
CL2013001589A1 (es) Uso de una emulsion que comprende 0,08% en peso o menos de aceite esencial antimicrobiano, goma acacia y agua para proporcionar un efecto antimicrobiano en una composicion acuosa; proceso para mejorar el efecto antimicrobiano de un aceite esencial antimicrobiano; y composicion acuosa que comprende una emulsion antimicrobiana.
ECSP088229A (es) Derivados de pirazolona como inhibidores de 11-beta hsd1
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
CU20120171A7 (es) Triazolopiridinas sustituidas
CL2007002034A1 (es) Compuestos derivados de hidroximoil-tetrazol; composicion fungicida que comprende dichos compuestos uso del compuesto o la composicion para controlar de forma curativa o preventiva los hongos fitopatogenos de las plantas o cultivos;y metodo para controlar hongos pitopatogenos de plantas o cultivos.
MY170054A (en) Herbicidal composition having improved herbicidal activity
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
BRPI0905995A2 (pt) "composição conservante para ser adicionada a um produto formulado, produto a ser conservado, método de fabricação do produto e uso de uma composição"
JP2011181765A5 (me)
WO2012136564A3 (en) Cosmetic composition comprising a cucurbic acid compound and an acrylic semicrystalline polymer
FR2968950B1 (fr) Composition cosmetique comprenant un compose d'acide cucurbique
AR091890A1 (es) Composiciones herbicidas protegidas que incluyen acido 4-amino-3-cloro-5-fluoro-6-(4-cloro-2-fluoro-3-metoxifenilo)piridina-2-carboxilico o un derivado del mismo y metodos para su uso
EP2351753A4 (en) PHENANTHROINDOLICIDIN DERIVATIVES AND THESE ACTIVE NF-kB-INHIBITORS
JP2012516858A5 (me)
PE20070828A1 (es) Composicion farmaceutica que contiene una sal de glicopirronio
NZ591529A (en) Chemical composition for skin care formulations